AI assistant
Sending…
ATAI Life Sciences N.V. — Director's Dealing 2021
Jun 24, 2021
32049_dirs_2021-06-24_7fc1780b-a4ff-43f4-9c38-7f5025042f30.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ATAI Life Sciences N.V. (ATAI)
CIK: 0001840904
Period of Report: 2021-06-22
Reporting Person: Rao Srinivas (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-22 | Common Shares | P | 3500 | $15.00 | Acquired | 3500 | Indirect |
More from ATAI Life Sciences N.V.
Regulatory Filings
2026
Mar 20
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 5
Capital/Financing Update
2025
Dec 5
Director's Dealing
2025
Nov 26
Interim / Quarterly Report
2025
Nov 12
Earnings Release
2025
Nov 12
Director's Dealing
2025
Nov 7